nocamycin E

Term ID

CHEBI:141187

Synonyms

(1S,2S,3R,5S,8S,9R,10R)-10-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.0(1,5)]dodecane-2-carboxylic acid
(2R,3S,3aS,5R,6R,7S,9aS)-5-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocine-3-carboxylic acid
21-demethyl-nocamycin I

Definition

An organic heterotricyclic compound and tetramic acid derivative isolated from a mutant strain of Saccharothrix syringae. Nocamycin E exhibits considerably lower antibacterial activity than the corresponding methyl ester, nocamycin I.

References

PMID:28818448

Ontology

ChEBI ( EBI )

Relationships

is a type of: enol gamma-lactam monocarboxylic acid olefinic compound organic heterotricyclic compound ... Show All 7 Terms

enol gamma-lactam monocarboxylic acid olefinic compound organic heterotricyclic compound spiroketal tetramic acids Show first 5 Terms
has_role: bacterial metabolite

bacterial metabolite Show first 5 Terms
inverse has_functional_parent: nocamycin I

nocamycin I Show first 5 Terms
inverse is_conjugate_base_of: nocamycin E(2-)

nocamycin E(2-) Show first 5 Terms
is_conjugate_acid_of: nocamycin E(2-)

nocamycin E(2-) Show first 5 Terms

Phenotype

Phenotype resulting from nocamycin E

Phenotype where environments contain nocamycin E

Phenotype modified by environments containing nocamycin E

Human Disease Model